statistiche ricercatore

Continente	#
NA - Nord America	544
EU - Europa	403
AS - Asia	380
AF - Africa	69
SA - Sud America	44
Continente sconosciuto - Info sul continente non disponibili	30
OC - Oceania	3
Totale	1.473

Nome	#
Deletions of Chromosome 7q Affect Nuclear Organization and HLXB9Gene Expression in Hematological Disorders	163
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma	159
Gene nuclear positioning in leukaemia with chromosome 7 rearrangements	154
Nuclear Repositioning of the Non-Translocated HLXB9 Allele in the Leukaemia Cell Line GDM-1 Harbouring a t(6;7)(q23;q36)	134
NLC for the delivery of new prodrugs in the treatment of uveal melanoma	113
NLC as promising platform to deliver new prodrugs in the treatment of ophthalmic cancer	111
Haloperidol metabolite II Valproate ester-loaded NLC as promising strategy for the treatment of Uveal Melanoma	103
Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma	101
Secondary metabolic profiles and anticancer actions from fruit extracts of immature pomegranates	101
HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic	90
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds	84
Preparation, characterization and in vitro evaluation of anticancer and antioxidant effects of luteolin-loaded nanocapsules	80
Localizzazione intranucleare ed espressione del gene HLXB9 nel differenziamento neuronale in vitro e nell insorgenza di disordini mielodi	80
Totale	1.473

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	41	0	5	0	2	5	1	9	3	3	3	0	10
2022/2023	108	10	11	0	14	8	13	0	27	18	0	5	2
2023/2024	70	2	11	0	9	1	17	0	4	1	2	19	4
2024/2025	300	8	43	16	32	53	42	13	5	7	22	31	28
2025/2026	868	54	65	122	66	117	208	62	13	55	44	31	31
2026/2027	19	10	9	0	0	0	0	0	0	0	0	0	0
Totale													1.473